hers glp 1 Novo Nordisk Drops Hims & Hers: Inside the Compounded GLP-1 Crisis Hims & Hers to offer

Funding The author(s) declared that financial support was not received for this work and/or its publication

Considerations to Weigh The individual ingredients in Patchie have been studied primarily through oral supplementation at doses higher than what the patches contain

Whether the right answer turns out to be a dose pause, a slower titration, supportive medication, a switch between Wegovy and Zepbound, or a different approach, we want to be in the conversation when that decision is made

Epub 2022 Jul 8

(The brand-name GLP-1s arent available as generics because the patents havent expiredNovo Nordisk has its US patent on semaglutide until 2032, and Eli Lilly on tirzepatide, until 2036.) But to be clear, compounders do still operate within a regulatory framework, albeit a less stringent one

Do not double dose to make up for a missed injection